15 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
SafeSharp Transseptal Needle (CLICK071, CLICK171, CLICK098, CLICK198)
FDA 510(k)
FDA Class 2
·Cardiovascular
Mui Scientific
FDA UDI
H & A Mui Enterprises Inc·10678467507850·24-Channel Customized Single-Use Anorectal Cath...
MCARE PF POWDER FREE LATEX EXAMINATION HIGH RISK GLOVES
FDA 510(k)
FDA Class 1
·General Hospital
SPLIT SEPTUM INJECTION SITES
FDA 510(k)
FDA Class 2
·General Hospital
ALINITY C CALCIUM2
FDA Adverse Event
Malfunction
·ABBOTT IRELAND DIAGNOSTICS DIVISION·Product code CJY·March 5, 2026
PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP
FDA Adverse Event
Malfunction
·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code OYC·November 10, 2014
DEEP BRAIN STIMULATION LEAD
FDA Adverse Event
Malfunction
·MPROC, VILLALBA·Product code MHY·August 17, 2011
6600
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·July 18, 2013
LIBERTY CYCLER SET, SINGLE CONN./EXT. DL
FDA Adverse Event
Malfunction
·REYNOSE MANUFACTURING·Product code FKX·August 19, 2011
BELLATEK HYBRID BAR 4 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·December 26, 2024
BELLATEK HYBRID BAR 4 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·January 6, 2025
BELLATEK¿ HYBRID BAR 5 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·February 18, 2025
BELLATEK HYBRID BAR 5 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·March 18, 2025
BELLATEK HYBRID BAR 4 IMPLANTS
FDA Adverse Event
Malfunction
·BIOMET 3I·Product code NHA·January 6, 2025
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014